Cathepsin S as a cancer target

被引:31
|
作者
Zhang, L. [1 ]
Wang, H. [1 ]
Xu, J. [1 ]
机构
[1] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China
关键词
cathepsin S; cancer; combined chemotherapy; inhibitors; HUMAN-MELANOMA CELLS; PROSTATE-CANCER; CYSTEINE CATHEPSINS; TUMOR INVASION; MEMBRANE PERMEABILIZATION; CLINICAL-SIGNIFICANCE; OXIDATIVE STRESS; B EXPRESSION; APOPTOSIS; INHIBITION;
D O I
10.4149/neo_2015_003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cathepsin S is a lysosomal enzyme that belongs to the papain family of cysteine proteases. Multiple studies indicate that cathepsin S acts not only as a crucial role in antigen presentation but also as an important protagonist of cancers. Cathepsin S has been shown to participate in dissolution and remodelling of connective tissue and basement membranes, resulting in the process of tumor growth, invasion, metastasis and angiogenesis. Therefore, cathepsin S has been suggested as a potential therapeutic target in cancer therapy. In the present study, we review the rapidly advancing field of cathepsin S in cancer therapy, highlighting the specific roles of cathepsin S in cancer.
引用
收藏
页码:16 / 26
页数:11
相关论文
共 50 条
  • [41] Dipeptide mimic oligomer transporter mediates intracellular delivery of Cathepsin D inhibitors: A potential target for cancer therapy
    Maynadier, Marie
    Vezenkov, Lubomir L.
    Amblard, Muriel
    Martin, Vincent
    Gandreuil, Celine
    Vaillant, Ophelie
    Gary-Bobo, Magali
    Basile, Ilaria
    Hernandez, Jean-Franois
    Garcia, Marcel
    Martinez, Jean
    JOURNAL OF CONTROLLED RELEASE, 2013, 171 (02) : 251 - 257
  • [42] Cathepsin S in liver fibrogenesis
    Kotsiliti, Eleni
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (10) : 631 - 631
  • [43] Cathepsin S in liver fibrogenesis
    Eleni Kotsiliti
    Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 631 - 631
  • [44] Bioavailable Cathepsin S inhibitors
    Thurairatnam, S
    Aldous, DJ
    Aguiar, J
    Bryant, C
    Graupe, M
    King, S
    Lai, J
    Leroy, V
    Letallec, JP
    Link, J
    Martichonok, V
    Patterson, J
    Timm, A
    Zipfel, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U159 - U159
  • [45] Differential regulation of cathepsin S and cathepsin L in interferon γ-treated macrophages
    Beers, C
    Honey, K
    Fink, S
    Forbush, K
    Rudensky, A
    JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02): : 169 - 179
  • [46] Crystal structure of cathepsin A, a novel target for the treatment of cardiovascular diseases
    Schreuder, Herman A.
    Liesum, Alexander
    Kroll, Katja
    Boehnisch, Britta
    Buning, Christian
    Ruf, Sven
    Sadowski, Thorsten
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 445 (02) : 451 - 456
  • [47] Cathepsin S (CTSS) in IgA nephropathy: an exploratory study on its role as a potential diagnostic biomarker and therapeutic target
    Fu, Shaojie
    Wu, Meiyan
    Cheng, Yanli
    Guan, Yan
    Yu, Jinyu
    Wang, Xueyao
    Su, Sensen
    Wu, Hao
    Ma, Fuzhe
    Zou, Yan
    Wu, Shan
    Xu, Hongzhao
    Xu, Zhonggao
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [48] Profilin 1 as a Target for Cathepsin X Activity in Tumor Cells
    Fonovic, Ursa Pecar
    Jevnikar, Zala
    Rojnik, Matija
    Doljak, Bojan
    Fonovic, Marko
    Jamnik, Polona
    Kos, Janko
    PLOS ONE, 2013, 8 (01):
  • [49] Cathepsin E: A novel target for regulation by class II transactivator
    Yee, CSK
    Yao, YX
    Li, P
    Klemsz, MJ
    Blum, JS
    Chang, CH
    JOURNAL OF IMMUNOLOGY, 2004, 172 (09): : 5528 - 5534
  • [50] Strategy in inhibition of cathepsin B, A target in tumor invasion and metastasis
    Lim, IT
    Meroueh, SO
    Lee, M
    Heeg, MJ
    Mobashery, S
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (33) : 10271 - 10277